STOCK TITAN

Redhill Biopharm Stock Price, News & Analysis

RDHL Nasdaq

Welcome to our dedicated page for Redhill Biopharm news (Ticker: RDHL), a resource for investors and traders seeking the latest updates and insights on Redhill Biopharm stock.

RedHill Biopharma Ltd (NASDAQ: RDHL) is a specialty biopharmaceutical leader focused on gastrointestinal and infectious disease therapies. This page provides investors and industry professionals with comprehensive updates on the company’s clinical developments, regulatory milestones, and strategic initiatives.

Access real-time announcements including FDA submissions, clinical trial results, and partnership agreements. Track progress across RedHill’s commercial products like Talicia for H. pylori and Aemcolo for travelers’ diarrhea, along with late-stage candidates such as opaganib in oncology and inflammatory diseases.

Our curated news collection enables informed decision-making by consolidating material events including earnings reports, intellectual property updates, and research collaborations. Content spans therapeutic area breakthroughs, management commentary, and market expansion activities.

Bookmark this page for streamlined access to verified RedHill Biopharma updates. Check regularly for developments impacting the company’s position in gastrointestinal therapeutics and pandemic preparedness research.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.34%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
covid-19
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25.95%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25.95%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
partnership
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.89%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.02%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.02%
Tags
none

FAQ

What is the current stock price of Redhill Biopharm (RDHL)?

The current stock price of Redhill Biopharm (RDHL) is $2 as of May 9, 2025.

What is the market cap of Redhill Biopharm (RDHL)?

The market cap of Redhill Biopharm (RDHL) is approximately 3.7M.
Redhill Biopharm

Nasdaq:RDHL

RDHL Rankings

RDHL Stock Data

3.66M
1.77M
6.77%
2.62%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Tel Aviv